Study guide
4.2 Glomerulonephritis, Nephrotic Syndrome & Electrolyte Imbalances
Combined Medical Services Examination UPSC CMS
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Structure, Logistics & Pattern
1.1 UPSC CMS Examination Overview & Eligibility 1.2 Two-Paper Written Exam Pattern & Negative Marking 1.3 Personality Test, Service Allocation & Career Paths
2 Chapter 2: General Medicine - Cardiology & Respiratory
2.1 Coronary Artery Disease & Acute Myocardial Infarction 2.2 Heart Failure & Cardiac Arrhythmias 2.3 Community-Acquired Pneumonia & Pulmonary Tuberculosis 2.4 COPD, Bronchial Asthma & Pulmonary Embolism
3 Chapter 3: General Medicine - Gastroenterology & Hepatology
3.1 Peptic Ulcer Disease & Upper GI Bleeding 3.2 Liver Cirrhosis & Portal Hypertension 3.3 Acute & Chronic Viral Hepatitis & Pancreatitis 3.4 Inflammatory Bowel Disease & Malabsorption Syndromes
4 Chapter 4: General Medicine - Nephrology & Endocrinology
4.1 Acute Kidney Injury & Chronic Kidney Disease 4.2 Glomerulonephritis, Nephrotic Syndrome & Electrolyte Imbalances 4.3 Diabetes Mellitus: Diagnosis, Complications & Management 4.4 Thyroid Disorders & Adrenal Gland Dysfunction
5 Chapter 5: General Medicine - Neurology, Haematology & Infection
5.1 Cerebrovascular Accidents (Stroke) & Epilepsy 5.2 Approach to Anaemia: Microcytic, Megaloblastic & Haemolytic 5.3 Acute & Chronic Leukaemias and Lymphomas 5.4 Tropical & Endemic Infections: Malaria, Typhoid & Dengue
6 Chapter 6: General Medicine - Emergency Medicine & Toxicology
6.1 Acute Anaphylaxis, Sepsis & Cardiopulmonary Resuscitation 6.2 Organophosphate, Paracetamol & Snakebite Toxicology 6.3 Common Dermatological & Psychiatric Manifestations in Internal Medicine 6.4 Musculoskeletal System & Adult Rheumatology
7 Chapter 7: Paediatrics - Neonatology & Child Growth
7.1 Newborn Care, Neonatal Resuscitation & APGAR Score 7.2 Prematurity, Low Birth Weight & Neonatal Jaundice 7.3 Infant & Child Growth & Developmental Milestones
8 Chapter 8: Paediatrics - Child Health & Nutrition
8.1 Protein-Energy Malnutrition (PEM) & Micronutrient Deficiencies 8.2 Universal Immunization Programme (UIP) & Child Vaccines 8.3 Pediatric Diarrhoea, Dehydration & Respiratory Emergencies 8.4 Birth Defects, Genetic Counseling, Autism & Paediatric Accidents/Poisoning
9 Chapter 9: Surgery - General Surgery, Wounds & Shock
9.1 Wound Healing, Surgical Site Infections & Gas Gangrene 9.2 Pathophysiology of Shock & Perioperative Fluid Therapy 9.3 Acute Abdomen: Appendicitis, Peritonitis & Intestinal Obstruction 9.4 Classification, Resuscitation & Management of Thermal Burns 9.5 Medicolegal & Ethical Issues in Surgery
10 Chapter 10: Surgery - Surgical Specialties I
10.1 Inguinal, Femoral & Ventral Hernias 10.2 Benign Breast Diseases & Breast Carcinoma 10.3 Solitary Thyroid Nodule & Thyroid Carcinoma 10.4 Benign Prostatic Hyperplasia & Renal Calculi
11 Chapter 11: Surgery - ENT, Orthopaedics & Anaesthesia
11.1 Acute Otitis Media, Tonsillitis & Epistaxis 11.2 Cataract, Glaucoma & Red Eye Emergencies 11.3 Principles of Fracture Management & Common Dislocation 11.4 Principles of Local, Regional & General Anaesthesia 11.5 Neurosurgery: Raised ICP, Head Injury & CNS Lesions 11.6 Thoracic Surgery: Chest Trauma, Pleural & Lung Disease
12 Chapter 12: Obstetrics - Antenatal Care & Complications
12.1 Antenatal Care, Maternal Nutrition & Fetal Assessment 12.2 Preeclampsia, Eclampsia & Gestational Hypertension 12.3 Antepartum Haemorrhage: Placenta Previa & Abruptio Placentae 12.4 Anemia in Pregnancy & Gestational Diabetes Mellitus 12.5 Spontaneous & Recurrent Abortion: Recognition & Management
13 Chapter 13: Obstetrics & Gynaecology - Labor & PPH
13.1 Normal Labor Mechanisms & Partograph Monitoring 13.2 Malpresentations, Breech & Obstructed Labor 13.3 Postpartum Haemorrhage (PPH) Causes & Management 13.4 Puerperal Sepsis & Postnatal Maternal Care
14 Chapter 14: Gynaecology & Family Planning
14.1 Abnormal Uterine Bleeding & Uterine Fibroids 14.2 Cervical Screening (Pap Smear) & Pelvic Inflammatory Disease 14.3 Temporary & Permanent Contraceptive Methods in India 14.4 Medical Termination of Pregnancy (MTP): Law & Methods
15 Chapter 15: PSM - Epidemiology & Biostatistics
15.1 Principles of Epidemiology & Disease Transmission 15.2 Observational & Experimental Epidemiological Study Designs 15.3 Evaluation of Screening Tests: Sensitivity, Specificity & Predictive Value 15.4 Biostatistics: Sampling, Central Tendency & Significance Testing
16 Chapter 16: PSM - Disease Epidemiology & Programmes
16.1 Epidemiology & Control of TB, Malaria & Dengue 16.2 National Tuberculosis Elimination Programme & NVBDCP 16.3 Epidemiology of Hypertension, Diabetes & Cancer in India 16.4 Cold Chain Management & Vaccine Logistics in India 16.5 Genetics and Health: Inheritance, Screening & Counseling
17 Chapter 17: PSM - Health Planning & Environmental Health
17.1 Demography, Fertility Rates & Family Welfare Indicators 17.2 Safe Water Supply, Waste Disposal & Air Pollution 17.3 Occupational Health Hazards & Pneumoconioses 17.4 Health Care Delivery System, Ayushman Bharat & National Health Mission 17.5 International Health: WHO, Global Agencies & SDG 3 17.6 Medical Sociology & Health Education
4.2 Glomerulonephritis, Nephrotic Syndrome & Electrolyte Imbalances
Key Takeaways Explain This Topic AI
Nephrotic Syndrome is defined by heavy proteinuria (>3.5 g/24h), hypoalbuminemia (<3.0 g/dL), generalized edema, hyperlipidemia, and lipiduria.
Minimal Change Disease (MCD) is the leading cause of nephrotic syndrome in children (effacement of podocyte foot processes on EM, steroid responsive), whereas Membranous Nephropathy (anti-PLA2R positive) and FSGS predominate in adults.
Nephritic Syndrome presents with dysmorphic hematuria, RBC casts, hypertension, oliguria, azotemia, and mild-to-moderate proteinuria (<3.5 g/24h).
IgA Nephropathy (Berger disease) presents as synpharyngitic gross hematuria (1-2 days after URTI) with normal complement, whereas PSGN develops 1-3 weeks post-streptococcal infection with low serum C3 levels.
Emergency management of severe hyperkalemia requires immediate IV Calcium Gluconate for cardiac membrane stabilization, followed by IV Regular Insulin + Dextrose and beta-agonists for intracellular K+ shifting.
Last updated: July 2026
Glomerulonephritis, Nephrotic Syndrome & Electrolyte Imbalances
Glomerular diseases and electrolyte disorders represent fundamental clinical topics frequently tested in UPSC CMS. A firm understanding of light microscopy, immunofluorescence (IF), electron microscopy (EM), complement patterns, and emergency resuscitation protocols is required.
1. Nephrotic vs. Nephritic Syndrome: Clinical Paradigm
Glomerular diseases typically present along a spectrum between pure Nephrotic Syndrome (podocyte injury resulting in breakdown of the filtration barrier to proteins) and pure Nephritic Syndrome (inflammatory glomerular capillary destruction leading to reactive hematuria and GFR decline).
- Diagnostic Feature Nephrotic Syndrome Nephritic Syndrome
- Proteinuria >3.5 g / 24 hours (Heavy) <3.5 g / 24 hours (Sub-nephrotic, typically 1–2 g/day)
- Serum Albumin <3.0 g/dL (Severe Hypoalbuminemia) Normal or slightly reduced
- Edema Severe, generalized ( Anasarca , periorbital) Mild to moderate (predominantly facial/periorbital)
- Hematuria Absent or microscopic Gross / Dysmorphic RBCs & RBC Casts
- Blood Pressure Usually Normal (or mild HTN) Hypertension (due to fluid retention)
- Renal Function (GFR) Often normal initially Reduced (Oliguria, Azotemia)
- Lipid Profile Hypercholesterolemia & Hypertriglyceridemia Usually Normal
- Urinary Sediment Fatty casts , Maltese cross (oval fat bodies) Dysmorphic RBCs, RBC Casts , WBCs
- 2. Major Nephrotic Syndromes
- A. Minimal Change Disease (MCD)
Epidemiology : Most common cause of nephrotic syndrome in children (80% of pediatric cases; peak age 2–6 years).
Pathophysiology : T-cell dysfunction producing cytokines that cause charge-barrier disruption of the glomerular basement membrane (GBM).
Microscopy :
Light Microscopy (LM): Normal glomeruli.
Immunofluorescence (IF): Negative (no immune complex deposits).
Electron Microscopy (EM): Effacement (fusion) of podocyte foot processes .
Clinical Features : Selective proteinuria (loss of albumin, but retention of higher molecular weight immunoglobulins).
Treatment : Oral Prednisolone (1 mg/kg/day or 60 mg/m²/day). Excellent steroid responsiveness (>90% complete remission).
B. Focal Segmental Glomerulosclerosis (FSGS)
Epidemiology : Most common cause of primary nephrotic syndrome in Black adults. Associated with HIV infection (HIV-associated nephropathy / collapsing variant), heroin abuse, morbid obesity, and nephron loss.
Microscopy : Segmental sclerosis affecting some but not all glomeruli on LM; diffuse podocyte foot process effacement on EM.
Clinical Course : Non-selective proteinuria, frequently steroid-resistant, high rate of progression to ESRD (50% in 10 years).
C. Membranous Nephropathy
Epidemiology : Most common primary nephrotic syndrome in older White adults (ages 40–60).
Etiology : 70% primary (idiopathic), driven by antibodies against Phospholipase A2 Receptor (anti-PLA2R) . Secondary causes: Hepatitis B & C , solid tumors (lung, colon, breast), NSAIDs, and SLE (Class V).
Microscopy :
LM: Diffuse thickening of the capillary wall.
IF: Granular IgG and C3 deposition along the GBM.
EM: Subepithelial immune complex deposits with "spike and dome" appearance on Jones silver stain.
Complications : Highest risk of Renal Vein Thrombosis among nephrotic syndromes (due to urinary loss of Antithrombin III).
Loading diagram... Glomerular Disease Differentiation & Complement Profile
- 3. Major Nephritic Syndromes
- A. Post-Streptococcal Glomerulonephritis (PSGN)
Etiology : Immune complex-mediated disease occurring 1 to 3 weeks after Group A Beta-Hemolytic Streptococcal (GABHS) pharyngitis or impetigo ( Streptococcus pyogenes , nephritogenic strains 12 and 49).
Clinical Presentation : Triad of Hematuria ("cola-colored" or smoky urine), Periorbital Edema , and Hypertension in a child.
Laboratory Findings : Elevated ASO titers, anti-DNase B, and persistently low serum C3 levels (which normalize by 6–8 weeks).
Histopathology :
LM: Diffuse hypercellular glomeruli (neutrophilic and lymphocytic infiltrate).
IF: "Starry sky" or lumpy-bumpy granular deposition of IgG and C3 along GBM and mesangium.
EM: Subepithelial electron-dense "humps" .
B. IgA Nephropathy (Berger Disease)
Epidemiology : The most common primary glomerulonephritis worldwide .
Clinical Presentation : Recurrent episodes of gross hematuria occurring contemporaneously (1–2 days) with or immediately following an upper respiratory or gastrointestinal infection ( Synpharyngitic Hematuria ).
Key Differentiating Points vs. PSGN :
Timing: 1–2 days (IgA) vs 1–3 weeks (PSGN).
Serum Complement: Normal C3/C4 levels in IgA Nephropathy vs Low C3 in PSGN.
Biopsy : Mesangial IgA deposition on immunofluorescence.
C. Rapidly Progressive Glomerulonephritis (RPGN)
Characterized by rapid loss of renal function over days to weeks with histologic evidence of Crescent formation (extracapillary proliferation of parietal epithelial cells and monocytes in Bowman's space) in >50% of glomeruli.
Type I (Anti-GBM Disease / Goodpasture Syndrome) : Autoantibodies against non-collagenous domain of alpha-3 chain of Type IV collagen. Linear IgG deposition along GBM. Presents with pulmonary hemorrhage + GN.
Type II (Immune Complex) : Granular deposition (PSGN, SLE, Henoch-Schönlein Purpura).
Type III (Pauci-immune) : Negative IF. Associated with ANCA vasculitides ( c-ANCA / PR3 in Granulomatosis with Polyangiitis; p-ANCA / MPO in Microscopic Polyangiitis).
- 4. Emergency Management of Electrolyte Imbalances
- A. Severe Hyperkalemia (Serum K⁺ >6.5 mEq/L or ECG Changes)
ECG Progression : Peaked T waves → PR prolongation & P wave flattening → QRS widening → Sine wave pattern → Ventricular Fibrillation / Asystole.
UPSC CMS Emergency Treatment Algorithm for Hyperkalemia :
Membrane Stabilization (Immediate) : IV Calcium Gluconate (10 mL of 10% solution over 2–5 mins) . Stabilizes cardiac myocyte membrane potential without changing serum K⁺ levels. (Use with caution in digoxin toxicity).
Shift K⁺ Intracellularly (Minutes) :
IV Regular Insulin (10 Units) + 50% Dextrose (50 mL / D50) to prevent hypoglycemia.
Nebulized Salbutamol (10–20 mg) (beta-2 agonist).
IV Sodium Bicarbonate (if concomitant metabolic acidosis exists).
Eliminate K⁺ from Body (Hours) :
Loop Diuretics (Furosemide IV).
Potassium Binders : Patiromer, Sodium Zirconium Cyclosilicate (SZC), Sodium Polystyrene Sulfonate (SPS).
Hemodialysis : Definitive treatment in renal failure.
B. Severe Hyponatremia (Serum Na⁺ <120 mEq/L or Symptomatic)
Classification : Determine plasma osmolality and volume status (Hypovolemic, Euvolemic [SIADH], Hypervolemic [Heart Failure, Cirrhosis]).
Symptomatic Management : Severe symptoms (seizures, altered mental status, coma) warrant immediate 3% Hypertonic Saline (100–150 mL IV bolus over 10–20 mins) to raise serum sodium by 4–6 mEq/L rapidly.
Safety Speed Limit : Rate of sodium correction must NOT exceed 8–10 mEq/L in 24 hours (or 0.5 mEq/L/hour) to prevent Osmotic Demyelination Syndrome (Central Pontine Myelinolysis) .